Synaptic Loss and the Pathophysiology of PTSD: Implications for Ketamine as a Prototype Novel Therapeutic
Crossref DOI link: https://doi.org/10.1007/s11920-017-0829-z
Published Online: 2017-08-26
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Krystal, John H.
Abdallah, Chadi G.
Averill, Lynette A.
Kelmendi, Benjamin
Harpaz-Rotem, Ilan
Sanacora, Gerard
Southwick, Steven M.
Duman, Ronald S.
License valid from 2017-08-26